Healthcare / Medical Care FacilitiesTokyo
$666.00
-24.00 (-3.53%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 14%
FCF escenarios
weak_data · normalized FCF $-2.8B · quality 25.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
36/100
D
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$23.8B
P/E
8.7x
↓EV/EBITDA
9.6x
↓ROE
13.5%
↑Gross Margin
42.6%
↓Debt/Equity
1.43
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+14.2%
FCF CAGR
—
FCF margin
-11.3%
FCF / Net income
-1.01x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $24.73B · net income $2.78B · FCF $-2.80B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $24.73B | $24.73B | $19.83B | $18.05B | $16.62B |
| Net Income | $2.78B | $2.78B | $2.03B | $1.05B | $980.4M |
| EBITDA | $4.60B | $4.60B | $4.45B | $2.90B | $2.67B |
| EPS | — | — | 63.12 | 35.18 | 27.82 |
| Gross Margin | 42.6% | 42.6% | 43.8% | 39.4% | 35.0% |
| Operating Margin | 9.6% | 9.6% | 11.6% | 10.5% | 5.2% |
| Net Margin | 11.2% | 11.2% | 10.2% | 5.8% | 5.9% |
| Balance Sheet | |||||
| Debt/Equity | 1.43 | 1.43 | 1.52 | 2.48 | 2.11 |
| Current Ratio | 2.15 | 2.15 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-2.80B | $-2.80B | $-52.6M | $-5.25B | $1.74B |
| Returns | |||||
| ROE | 13.5% | 13.5% | 11.3% | 9.7% | 10.1% |
| Valuation | |||||
| P/E | 8.68 | 8.68 | 14.73 | — | — |
| EV/EBITDA | 9.58 | 9.58 | 10.31 | — | — |
| P/B | 1.16 | 1.16 | 1.66 | — | — |
| Growth & Yield | |||||
| Revenue Growth | 24.7% | 24.7% | 9.9% | 8.7% | — |
| EPS Growth | — | — | 79.4% | 26.4% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-40.9%
Start / end P/E
n/dx → n/dx
EPS bridge
63.12 → n/d
Residual
-40.9%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.